Affordable Access

deepdyve-link
Publisher Website

Healthcare Resource Use and Direct Costs in Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Large US Cohort.

Authors
  • Greenberg, Jeffrey D1
  • Palmer, Jacqueline B2
  • Li, Yunfeng2
  • Herrera, Vivian2
  • Tsang, Yuen2
  • Liao, Minlei2
  • 1 From the Department of Rheumatology, New York University School of Medicine, New York, New York; Health Economics and Outcomes Research, and Outcomes Research Methods and Analytics, US Health Economics and Outcomes Research, Novartis Pharmaceuticals Corp., East Hanover; KMK Consulting Inc., Florham Park, New Jersey; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.J.D. Greenberg, MD, MPH, New York University Hospital for Joint Disease, and Department of Rheumatology, New York University School of Medicine; J.B. Palmer, PharmD, Health Economics and Outcomes Research, Novartis; Y. Li, PhD, Outcomes Research Methods and Analytics, US Health Economics & Outcomes Research, Novartis; V. Herrera, PharmD, Health Economics and Outcomes Research, Novartis; Y. Tsang, PharmD, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy; M. Liao, MA, KMK Consulting Inc. [email protected] , (Jersey)
  • 2 From the Department of Rheumatology, New York University School of Medicine, New York, New York; Health Economics and Outcomes Research, and Outcomes Research Methods and Analytics, US Health Economics and Outcomes Research, Novartis Pharmaceuticals Corp., East Hanover; KMK Consulting Inc., Florham Park, New Jersey; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.J.D. Greenberg, MD, MPH, New York University Hospital for Joint Disease, and Department of Rheumatology, New York University School of Medicine; J.B. Palmer, PharmD, Health Economics and Outcomes Research, Novartis; Y. Li, PhD, Outcomes Research Methods and Analytics, US Health Economics & Outcomes Research, Novartis; V. Herrera, PharmD, Health Economics and Outcomes Research, Novartis; Y. Tsang, PharmD, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy; M. Liao, MA, KMK Consulting Inc. , (Jersey)
Type
Published Article
Journal
The Journal of rheumatology
Publication Date
Jan 01, 2016
Volume
43
Issue
1
Pages
88–96
Identifiers
DOI: 10.3899/jrheum.150540
PMID: 26628601
Source
Medline
Keywords
License
Unknown

Abstract

Biologic use, age, and comorbidities were major determinants of all-cause direct costs in patients with AS and PsA.

Report this publication

Statistics

Seen <100 times